Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Salivary Gland Adenoma, Pleomorphic × Docetaxel × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 60 Carcinoma, Non-Small-Cell Lung 56 Stomach Neoplasms 29 Nasopharyngeal Carcinoma 21 Lung Neoplasms 20 Prostatic Neoplasms 18 Squamous Cell Carcinoma of Head and Neck 11 Esophageal Neoplasms 9 Neoplasm Metastasis 8 Head and Neck Neoplasms 6 Ovarian Neoplasms 4 Neoplasms 4 Inflammatory Breast Neoplasms 4 HER2-positive Breast Cancer 4 Carcinoma, Squamous Cell 4 Adenocarcinoma 4 Triple Negative Breast Neoplasms 3 Sarcoma 3 Pancreatic Neoplasms 3 Nasopharyngeal Neoplasms 3 NSCLC 3 Hypopharyngeal Neoplasms 3 Esophageal Squamous Cell Carcinoma 3 Carcinoma, Ovarian Epithelial 3 Breast Diseases 3 Adenocarcinoma of Lung 3 Uterine Cervical Neoplasms 2 Tongue Neoplasms 2 Squamous Cell Lung Cancer 2 Solid Tumor 2

Interventions

Gonadotropin-Releasing Hormone 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00764166 2008-10-01

RisingPSA

Assistance Publique - Hôpitaux de Paris

Phase 3 Unknown

Salivary Gland Adenoma, Pleomorphic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡